Under construction – not a live service
Sign in
Taking people in FranceNo phase

Comparing bougie sizes in sleeve gastrectomy for morbid obesity

Compares two bougie sizes during stomach surgery for severe obesity, to see leak rates.

Plain-language title generated from the registry record
Registry title: Bougie Sleeve Trial

Key facts

Where
Boulogne-Billancourt, Caen, Clamart, Créteil, La Tronche, Limoges, Longjumeau, Paris, Poissy, Saint-Denis, Saint-Etienne, and Vandœuvre-lès-Nancy, FranceSee the 12 sites

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 70 years old?

Source: NCT02937649, who can take part

Where in France

  • Hôpital Ambroise-ParéBoulogne-Billancourt, FranceNo longer taking part
  • Hôpital Côte de Nacre - CHU de CaenCaen, FranceNo longer taking part
  • CHU Antoine BéclèreClamart, FranceTaking people
  • Centre Hospitalier Intercommunal de CréteilCréteil, FranceNo longer taking part
  • Hôpital MICHALLON, CHU de GrenobleLa Tronche, FranceNo longer taking part
  • Hôpital Dupuytren - LimogesLimoges, FranceNo longer taking part
  • Clinique de l'YvetteLongjumeau, FranceTaking people
  • Service de chirurgie générale et digestive, œsogastrique et bariatrique - Hôpital BichatParis, FranceTaking people
  • CHI - Centre Hospitalier Poissy/Saint-Germain-en-LayePoissy, FranceTaking people
  • CH Saint DenisSaint-Denis, FranceTaking people
  • Clinique Mutualiste ChirurgicaleSaint-Etienne, FranceNo longer taking part
  • Hôpitaux de BraboisVandœuvre-lès-Nancy, FranceTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Assistance Publique - Hôpitaux de Paris
Trial code
NCT02937649
Record updated
6 April 2025
Original description
Staple-line leak is the most frequent and incapacitating complication after laparoscopic sleeve gastrectomy (LSG). The aim of this prospective randomized trial is to compare the staple-line leak rate after LSG according to the use of a standard bougie calibre (34, 36 or 38 Fr) or 48-Fr, assuming that a higher diameter is correlated with a lower risk of leak, without lowering long-term weight loss.Read full original descriptionShow less

Multicentric Randomized Prospective Study Assessing the Impact of the Bougie Calibration Size During Laparoscopic Sleeve Gastrectomy on the Rate of Postoperative Staple-line Leak Rate

Staple-line leak is the most frequent and incapacitating complication after laparoscopic sleeve gastrectomy (LSG). The aim of this prospective randomized trial is to compare the staple-line leak rate after LSG according to the use of a standard bougie calibre (34, 36 or 38 Fr) or 48-Fr, assuming that a higher diameter is correlated with a lower risk of leak, without lowering long-term weight loss.

Inclusion: Patients between 18 and 70 years; Sleeve gastrectomy as a primary bariatric procedure; Body Mass Index (BMI) > 40 kg/m² or > 35 kg/m² associated with at least one comorbidity susceptible to improve after surgery (including arterial hypertension, obstructive sleep apnea syndrome and other severe respiratory disorders, severe metabolic disorders, particularly type 2 diabetes, incapacitating osteo-articular disorders, non alcoholic steatohepatitis); Decision for intervention after multidisciplinary discussion; Written informed consent.

Exclusion: Previous upper abdominal surgery (cholecystectomy excepted); Esophagus pathology or disorder (esophageal varices, esophageal diverticula, esophageal tumors, esophageal strictures); Coagulation disorder; Patient with known silicon allergy (calibration bougie contains medical silicon); ASA (American Society of Anesthesiologists) score > 3; Ongoing pregnancy or breast feeding; Patient not covered by social security service and patient on AME; Patient under legal guardianship and trusteeship; More generally, all other contraindications to the use of esophageal bougie MID-TUBE that have been the subject of a scientific paper or have been identified by the practitioner or practitioners.

ClinicalTrials.gov NCT02937649